View in EDS HTML Full Text PDF Full Text

Sex-specific gene and pathway modeling of inherited glioma risk.

Saved in:
Bibliographic Details
Title: Sex-specific gene and pathway modeling of inherited glioma risk.
Authors: Ostrom QT; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Coleman W; University School, Chagrin Falls, Ohio, USA., Huang W; Case Western Reserve University, Cleveland, Ohio, USA., Rubin JB; Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA; Department of Neuroscience, Washington University School of Medicine, St Louis, Missouri, USA., Lathia JD; Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Berens ME; Cancer and Cell Biology Division, The Translational Genomics Research Institute, Phoenix, Arizona, USA., Speyer G; Cancer and Cell Biology Division, The Translational Genomics Research Institute, Phoenix, Arizona, USA., Liao P; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Wrensch MR; Department of Neurological Surgery, School of Medicine, University of California San Francisco, San Francisco, California, USA., Eckel-Passow JE; Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA., Armstrong G; Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Rice T; Department of Neurological Surgery, School of Medicine, University of California San Francisco, San Francisco, California, USA., Wiencke JK; Department of Neurological Surgery, School of Medicine, University of California San Francisco, San Francisco, California, USA., McCoy LS; Department of Neurological Surgery, School of Medicine, University of California San Francisco, San Francisco, California, USA., Hansen HM; Department of Neurological Surgery, School of Medicine, University of California San Francisco, San Francisco, California, USA., Amos CI; Institute for Clinical and Translational Research, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Bernstein JL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Claus EB; School of Public Health, Yale University, New Haven, Connecticut, USA.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey, United Kingdom., Il'yasova D; Department of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, Georgia, USA.; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA., Johansen C; Oncology Clinic, Finsen Center, Rigshospitalet and Survivorship Research Unit, The Danish Cancer Society Research Center, Copenhagen, Denmark., Lachance DH; Department of Neurology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA., Lai RK; Departments of Neurology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Merrell RT; Department of Neurology, NorthShore University HealthSystem, Evanston, Illinois, USA., Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Sadetzki S; Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Schildkraut JM; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA., Shete S, Andersson U; Department of Radiation Sciences, Faculty of Medicine, Umea° University, Umea°, Sweden., Rajaraman P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.; Core Genotyping Facility, National Cancer Institute, SAIC-Frederick, Inc, Gaithersburg, Maryland, USA., Linet MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA., Wang Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.; Core Genotyping Facility, National Cancer Institute, SAIC-Frederick, Inc, Gaithersburg, Maryland, USA.; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.; Core Genotyping Facility, National Cancer Institute, SAIC-Frederick, Inc, Gaithersburg, Maryland, USA., Melin B; Department of Radiation Sciences, Faculty of Medicine, Umea° University, Umea°, Sweden., Bondy ML; Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Barnholtz-Sloan JS; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Corporate Authors: GliomaScan consortium
Source: Neuro-oncology [Neuro Oncol] 2019 Jan 01; Vol. 21 (1), pp. 71-82.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1523-5866
DOI:10.1093/neuonc/noy135